Chemical Compound
Escitalopram oxalate
CAS Registry Number
219861-08-2
Primary Record
Escitalopram oxalate
- In stock
- 9,659 g
- Purity
- 98.2 %
- CAS
- 219861-08-2
Compound Identifiers & Properties
- CAS
- 219861-08-2
- PubChem CID
- 146571
- SMILES
- CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
- Canonical SMILES
- CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.O=C(O)C(=O)O
Names & Synonyms
- Escitalopram oxalate
- Lexapro
- Escitalopram
- 219861-08-2
- Cipralex
- (S)-Citalopram Oxalate
- Escitslopram
- Seroplex
- Esertia
- Gaudium
- Entact
- Citalopram Oxalate
- Escitalopram (oxalate)
- Cipra-Pro
- Escitalopram Oral
- Escitalopramoxalate
- (S)-Citalopram
- (S)-(+)Citalopram oxalate
- Lexapro (TN)
- Escitalopram (as oxalate)
- (R)-Citalopram Oxalate
- Citalopram oxalate, (s)-
- 5U85DBW7LO
- RefChem:56379
- Escitalopram oxalate CRS
- (S)-(+)-Citalopram Oxalate
- AC1L3TGZ
- (S)-Escitalopram Oxalate
- Escitalopram oxalate [USAN]
- Escitalopram Oral Solution
- DTXSID1046003
- C22H23FN2O5
- UNII-5U85DBW7LO
- S-(+)-Citalopram oxalate
- Citalopram Oxalate S-Isomer
- MFCD06407826
- SCHEMBL35123
- DTXCID9026003
- cc-372
- MLS001401408
- NSC-758934
- SPECTRUM1505216
- (+)-(S)-Citalopram oxalate
- Lu 26-054-0
- KTGRHKOEFSJQNS-BDQAORGHSA-N
- MLD-55
- orb1300720
- CHEMBL1200322
- Lu-26-054-0
- SCHEMBL30223023
- Escitalopram oxalate (JAN/USP)
- MSK11176O
- (S)-(+ )-Citalopram oxalate
- AOB4715
- ESCITALOPRAM OXALATE [MI]
- LU-26-054-O
- Escitalopram oxalate [USAN:USP]
- Escitalopram (oxalate) (Standard)
- ESCITALOPRAM OXALATE [JAN]
- GLXC-03026
- HMS2051D11
- HMS2231M16
- HMS3370I17
- HMS3393D11
- HMS3713D16
- HY-14258AR
- Pharmakon1600-01505216
- BCP05686
- Escitalopram Oxalate (1249406)
- ESCITALOPRAM OXALATE [VANDF]
- Tox21_111535
- CCG-39559
- CID146571
- EBC-80071
- ESCITALOPRAM OXALATE [MART.]
- HB1804
- HY-14258A
- NCGC00095903-01
- NP3630
- NSC758934
- ESCITALOPRAM OXALATE [USP-RS]
- ESCITALOPRAM OXALATE [WHO-DD]
- AKOS016340275
- Tox21_111535_1
- AC-6770
- AN-9671
- CS-2054
- Escitalopram for system suitability CRS
- FC20465
- KS-1263
- NC00194
- NSC 758934
- SB17454
- Escitalopram oxalate CRS (Y0001796)
- NCGC00178555-02
- AK138215
- AN-13009
- BC164423
- Citalopram S-Isomer; Escitalopram Oxalate
- CPD000469191
- ESCITALOPRAM OXALATE [ORANGE BOOK]
- SAM001246668
- SMR000469191
- SY067062
- ESCITALOPRAM OXALATE [EP MONOGRAPH]
- (S)-Citalopram oxalate - Bio-X trade mark
- AB0012102
- ESCITALOPRAM OXALATE [USP MONOGRAPH]
- LS-183519
- TL8001823
- B2238
- CAS-219861-08-2
- E0958
- ST24046691
- 4-(2-chloroacetyl)-1H-pyrrole-2-carbaldehyde
- D02567
- Escitalopram oxalate, >=98% (HPLC), powder
- J90016
- (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid
- (S)-1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate
- 861E082
- A852070
- SR-01000763053
- SR-01000763053-3
- Q27262882
- 5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-,ethanedioate (1:1)
- Z3235136057
- S-(+)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate
- 219861-53-7
- S-(+)-5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, oxalate
- Escitalopram oxalate, EuropePharmacopoeia (EP) Reference Standard
- (1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Ethanedioate
- 128196-01-0
- 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1)
- Escitalopram oxalate, United States Pharmacopeia (USP) Reference Standard
- Escitalopram for system suitability, EuropePharmacopoeia (EP) Reference Standard
- Escitalopram Oxalate, Pharmaceutical Secondary Standard; Certified Reference Material
- (+)-(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate
- (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; oxalic acid
- (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile; oxalic acid
- (1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;oxalic acid
- (S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate
- 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1)
- 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1)
- Escitalopram Oxalate; (S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Ethanedioate; (+)-(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate
- Oxalic acid--(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile (1/1)
- S-(+)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate